1.
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Swiss Med Wkly [Internet]. 2017 Nov. 20 [cited 2025 Oct. 24];147(4748):w14544. Available from: https://smw.ch/index.php/smw/article/view/2420